|
Diabetes Medication Article
Why is Insulin prescribed?
Insulin is a hormone produced in the pancreas. Insulin is necessary to move sugar from the blood into other body tissues where it is needed for energy. Insulin also helps the body to metabolize (process) carbohydrates, fats, and proteins from the diet. In a person with diabetes, the pancreas does not produce enough insulin for the body's needs, so additional insulin is required. It must be injected because stomach acid would destroy it if taken by mouth. Insulin controls, but does not cure, diabetes. It must be taken regularly. People with diabetes gradually develop serious nerve, blood vessel, kidney, and eye problems, especially if the diabetes is not controlled properly.
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
http://www.diabetestestingcenter.com
http://www.attentiondeficitdisordercenter.com
http://www.anxietydisordernews.info
Apidra News
Apidra
Font: In my experience, most class 2's recieve a panel. If a panel is conviened then the PDUFA will likely be pushed 6 months back to about June 2011 with the panel meeting a few months prior. Besides the obvious delay ...
Read moreI'm going to just say it: Mannkind is garbage - Seekingalpha.com
Sanofi-Aventis SA , the French drugmaker that’s planning the takeover of Genzyme Corp. , reported a 7.6 percent increase in second-quarter profit on higher sales of its Lantus and Apidra diabetes treatments ...
Read moreSanofi Second-Quarter Profit Climbs 7.6% on Demand for Diabetes Medicines - Bloomberg
Sanofi-Aventis , the French pharmaceutical company considering an $18.6 billion bid for the U.S. biotechnology firm Genzyme , said profits jumped in the second quarter due to strong sales of its diabetes drugs ...
Read moreSanofi Mum on Genzyme as It Posts Higher Profit - New York Times Blogs
European stock-index futures rose as better-than-estimated earnings from Siemens AG and BASF SE outweighed a Federal Reserve report that showed growth slowed in some areas of the economy. U.S. futures climbed. Siemens ...
Read moreEuropean Stock-Index Futures Advance; Siemens, BASF May Gain on Earnings - Bloomberg
July 29 (Bloomberg) -- European stock-index futures rose as better-than-estimated earnings from Siemens AG and BASF SE outweighed a Federal Reserve report that showed growth slowed in some areas of the economy ...
Read moreEuropean Stock-Index Futures Advance; Siemens, BASF May Gain - BusinessWeek
July 29 (Bloomberg) -- European stocks rose as better-than- estimated earnings at companies from Siemens AG to BASF SE and AstraZeneca Plc outweighed a Federal Reserve report that showed growth slowed in some ...
Read moreEuropean Stocks Rise; Siemens, BASF, AstraZeneca Lead Advance - BusinessWeek
SAN DIEGO , June 28 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO ) today announced clinical trial results showing that the addition of its proprietary rHuPH20 (recombinant human hyaluronidase, PH20 ...
Read moreCoinjection of Halozyme's rHuPH20 Enzyme Accelerates the Absorption and Action of Mealtime Insulin ... - StreetInsider.com
Halozyme Therapeutics, Inc. (Nasdaq: HALO ) today announced clinical trial results showing that the addition of its proprietary rHuPH20 (recombinant human hyaluronidase, PH20) enzyme to three different mealtime insulin ...
Read moreHalozyme Therapeutics (HALO) Announces rHuPH20 Accelerates Insulin Absorption - StreetInsider.com
( EMAILWIRE.COM , July 30, 2010 ) New York, NY -Covidien plc (NYSE:COV) lost 4.23% to $36.88 on over 14.07 million shares. The company reported an adjusted profit that beat estimates on better margins, but saw weak ...
Read moreHealthcare Stocks Closed Lower (COV, LIFE, SNY, BMY) - Emailwire
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets ...
Read more